Dr. Abidi Pharmaceutical Laboratories (DABID) cost of goods sold
What makes up the cost of goods sold
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Direct consumable materials | 90,360,074 | 30,430,370 | 21,157,786 | 17,528,643 | 9,256,101 | 6,022,331 |
| Direct production wages | 3,751,021 | 2,221,839 | 1,583,881 | 1,198,363 | 595,128 | 354,968 |
| Production overhead | 34,195,968 | 11,486,288 | 7,770,370 | 4,871,611 | 2,663,072 | 1,517,692 |
| Total | 128,307,063 | 44,138,497 | 30,512,037 | 23,598,617 | 12,514,301 | 7,894,991 |
| Net work-in-process inventory | -388,197 | 38,868 | -267,020 | -1,072,024 | -238,831 | 87,667 |
| Cost of goods manufactured | 127,918,866 | 44,139,778 | 30,215,383 | 22,525,550 | 12,273,772 | 7,973,578 |
| Finished goods inventory at beginning of period | 21,516,899 | 15,280,672 | 11,538,060 | 4,348,854 | 3,129,868 | 2,140,520 |
| Finished goods inventory at end of period | -59,648,491 | -18,938,139 | -15,499,013 | -9,231,942 | -4,152,906 | -3,354,253 |
| Cost of goods sold | 89,787,274 | 40,482,311 | 26,254,430 | 17,642,462 | 11,250,734 | 6,759,845 |
| Cost of services rendered | 4,083,817 | -664,403 | -583,688 | -415,863 | -338,506 | -318,778 |
| Total cost | 93,871,091 | 39,817,908 | 25,670,742 | 17,226,599 | 10,912,228 | 6,441,067 |
Reporting periods
34 periods are on file for this report, from the period ending 1396/09/30 to the period ending 1405/06/31.